SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-030732
Filing Date
2017-02-03
Accepted
2017-02-03 16:16:02
Documents
4
Period of Report
2017-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d322883d8k.htm 8-K 35625
2 EX-1.1 d322883dex11.htm EX-1.1 170768
3 EX-3.1 d322883dex31.htm EX-3.1 89786
4 EX-3.2 d322883dex32.htm EX-3.2 12247
  Complete submission text file 0001193125-17-030732.txt   310027
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 17572287
SIC: 2834 Pharmaceutical Preparations